Article
IRF4 instructs effector Treg differentiation and immune suppression in human cancer
10 Mar 2020
Abstract excerpt
The molecular mechanisms responsible for the high immunosuppressive capacity of CD4+ Tregs in tumors are not well known. High-dimensional single-cell profiling of T cells from chemotherapy-naive individuals with non-small-cell lung cancer identified the transcription factor IRF4 as specifically expressed by a subset of intratumoral CD4+ effector Tregs with superior suppressive activity. In contrast to the IRF4-...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
